收稿日期: 2018-10-11
网络出版日期: 2020-08-06
基金资助
国家自然科学基金(81271148);国家自然科学基金(8140030482)
Effect of Porphyromonas gingivalis infection on atherosclerosis in apolipoprotein-E knockout mice
Received date: 2018-10-11
Online published: 2020-08-06
Supported by
National Natural Science Foundation of China(81271148);National Natural Science Foundation of China(8140030482)
目的: 探讨牙龈卟啉单胞菌(Porphyromonas gingivalis,P. gingivalis)引起的炎症和氧化应激反应对动脉粥样硬化的影响及作用机制。方法: 采用8周龄载脂蛋白e基因敲除(ApoE knockout,ApoE-/-)小鼠建立动脉粥样硬化动物模型,将小鼠随机分为两组:(1)磷酸盐缓冲液(phosphate buffered saline,PBS)健康对照组:8只ApoE-/-小鼠,普通饮食+PBS鼠尾静脉注射;(2)P. gingivalis感染组:8只ApoE-/-小鼠,普通饮食+P. gingivalis鼠尾静脉注射。1周3次,隔天1次,共10次。4周后处死,取心脏组织进行油红O染色,血清进行酶联免疫吸附测定(enzyme-linked immunosorbent assay,ELISA),主动脉进行实时荧光定量PCR以及Western blot检测。结果: P. gingivalis 感染组较PBS健康对照组可以显著加重ApoE-/-小鼠动脉粥样硬化斑块的形成,增加血清中炎症介质,如白细胞介素(interleukin,IL)-1β、IL-6和肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)以及氧化应激介质8-羟脱氧鸟苷(8-hydroxy-2-deoxyguanosine,8-OHDG)表达,增加主动脉组织中IL-1β、IL-6、TNF-α、NADPH 氧化酶(NADPH oxidase,NOX)-2和NOX-4基因的mRNA水平。P. gingivalis感染后在主动脉组织中观察到核转录因子-κB(nuclear factor-kappa B,NF-κB)表达有增高趋势。结论: P.gingivalis感染会加速ApoE-/-小鼠动脉粥样硬化进程,诱导氧化应激和炎症反应;NF-κB信号通路可能是P. gingivalis加速动脉粥样硬化形成的重要作用机制。
轩艳 , 蔡宇 , 王啸轩 , 石巧 , 邱立新 , 栾庆先 . 牙龈卟啉单胞菌感染对载脂蛋白e基因敲除小鼠动脉粥样硬化的影响[J]. 北京大学学报（医学版）, 2020 , 52(4) : 743 -749 . DOI: 10.19723/j.issn.1671-167X.2020.04.028
Objective: Studies have indicated that periodontal pathogen Porphyromonas gingivalis (P. gingivalis) infection may contributed to accelerate the development of atherosclerosis. The aim of this study was to investigate the effect of inflammation, oxidative stress and the mechanism on atherosclerosis in apolipoprotein-E knockout (ApoE-/-) mice with P. gingivalis infection. Methods: Eight-week-old male ApoE-/- mice (C57BL/6) were maintained under specific pathogen-free conditions and fed regular chow and sterile water after 1 weeks of housing. The animals were randomly divided into two groups: (a) ApoE-/- + PBS (n=8); (b) ApoE-/- + P.gingivalis strain FDC381 (n=8). Both of the groups received intravenous injections 3 times per week for 4 weeks since 8 weeks of age. The sham control group received injections with phosphate buffered saline only, while the P. gingivalis-challenged group with P.gingivalis strain FDC381at the same time. After 4 weeks, oxidative stress mediators and inflammation cytokines were analyzed by oil red O in heart, Enzyme linked immunosorbent assay (ELISA) in serum, quantitative real-time PCR and Western blot in aorta. Results: In our study, we found accelerated development of atherosclerosis and plaque formation in aorta with oil red O staining, increased oxidative stress markers [8-hydroxy-2-deoxyguanosine (8-OHdG), NADPH oxidase (NOX)-2 and NOX-4], as well as increased inflammation cytokines [interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF-α)] in the serum and aorta of the P. gingivalis-infected ApoE-/- mice. Compared with the control group, there was a significant increase protein level of nuclear factor-kappa B (NF-κB) in aorta after P. gingivalis infection. Conclusion: Our results suggest that chronic intravenous infection of P. gingivalis in ApoE-/- mice could accelerate the development of atherosclerosis by disturbing the lipid profile and inducing oxidative stress and inflammation. The NF-κB signaling pathway might play a potential role in the P. gingivalis-accelerated atherogenesis.
| [1] | Cutler CW, Kalmar JR, Genco CA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis[J]. Trends Microbiol, 1995,3(2):45-51. |
| [2] | Holt SC, Kesavalu L, Walker S, et al. Virulence factors of Porphyromonas gingivalis[J]. Periodontol 2000,1999(20):168-238. |
| [3] | DeStefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality[J]. BMJ, 1993,306(6879):688-691. |
| [4] | Southerland JH, Taylor GW, Moss K, et al. Commonality in chronic inflammatory diseases: Periodontitis, diabetes, and coronary artery disease[J]. Periodontol 2000, 2006,40(1):130-143. |
| [5] | Dogan B, Buduneli E, Emingil G, et al. Characteristics of periodontal microflora in acute myocardial infarction[J]. J Periodontol, 2005,76(5):740-748. |
| [6] | Jain A, Batista EL Jr, Serhan C, et al. Role for periodontitis in the progression of lipid deposition in an animal model[J]. Infect Immun, 2003,71(10):6012-6018. |
| [7] | Ishihara K, Nabuchi A, Ito R, et al. Correlation between detection rates of periodontopathic bacterial DNA in carotid coronary stenotic artery plaque and in dental plaque samples[J]. J Clin Microbiol, 2004,42(3):1313-1315. |
| [8] | Nakano K, Inaba H, Nomura R, et al. Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients[J]. Oral Microbiol Immunol, 2008,23(2):170-172. |
| [9] | Kozarov EV, Dorn BR, Shelburne CE, et al. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis[J]. Arterioscler Thromb Vasc Biol, 2005,25(3):e17-e18. |
| [10] | Fukasawa A, Kurita-Ochiai T, Hashizume T, et al. Porphyromonas gingivalis accelerates atherosclerosis in C57BL/6 mice fed a high-fat diet[J]. Immunopharmacol Immunotoxicol, 2012,34(3):470-476. |
| [11] | Yu H, Qi LT, Liu LS, et al. Association of carotid intima-media thickness and atherosclerotic plaque with periodontal status[J]. J Dent Res, 2014,93(8):744-751. |
| [12] | Lin G, Chen S, Lei L, et al. Effects of intravenous injection of Porphyromonas gingivalis on rabbit inflammatory immune response and atherosclerosis [J/OL]. Mediators Inflamm, 2015: 364391. doi: 10.1155/2015/364391. |
| [13] | Paigen B, Morrow A, Holmes PA, et al. Quantitative assessment of atherosclerotic lesions in mice[J]. Atherosclerosis, 1987,68(3):231-240. |
| [14] | Bélanger M, Rodrigues PH, Dunn WA, et al. Autophagy: A highway for Porphyromonas gingivalis in endothelial cells[J]. Autophagy, 2006,2(3):165-170. |
| [15] | Iwai T. Periodontal bacteremia and various vascular diseases[J]. J Periodontal Res, 2009,44(6):689-694. |
| [16] | Campbell LA, Rosenfeld ME. Infection and atherosclerosis deve-lopment[J]. Arch Med Res, 2015,46(5):339-350. |
| [17] | Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction[J]. BMJ, 1989,298(6676):779-781. |
| [18] | Chiu B. Multiple infections in carotid atherosclerotic plaques[J]. Am Heart J, 1999,138(5 Pt 2):S534-S536. |
| [19] | Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques[J]. J Periodontol, 2000,71(10):1554-1560. |
| [20] | Nakano K, Miyamoto E, Tamura K, et al. Distribution of 10 periodontal bacterial species in children and adolescents over a 7-year period[J]. Oral Dis, 2008,14(7):658-664. |
| [21] | Wada K, Kamisaki Y. Roles of oral bacteria in cardiovascular diseases. From molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm[J]. J Pharmacol Sci, 2010,113(2):115-119. |
| [22] | Miyakawa H, Honma K, Qi M, et al. Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis[J]. J Periodontal Res, 2004,39(1):1-9. |
| [23] | Li XY, Wang C, Xiang XR, et al. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages[J]. Oncol Rep, 2013,30(3):1329-1336. |
| [24] | Qi M, Miyakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation[J]. Microb Pathog, 2003,35(6):259-267. |
| [25] | Ross R. Atherosclerosis is an inflammatory disease[J]. Am Heart J, 1999,138(5 Pt 2):S419-S420. |
| [26] | Hansson GK. Inflammation and immune response in atherosclerosis[J]. Curr Atheroscler Rep, 1999,1(2):150-155. |
| [27] | Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis[J]. Nature, 2011,473(7347):317-325. |
| [28] | Ramji DP, Davies TS. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets[J]. Cytokine Growth Factor Rev, 2015,26(6):673-685. |
| [29] | Rosenson RS, Elliott M, Stasiv Y, et al. Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease[J]. Eur Heart J, 2011,32(8):999-1005. |
| [30] | Hayashi C, Papadopoulos G, Gudino CV, et al. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen[J]. J Immunol, 2012,189(7):3681-3688. |
| [31] | Gibson FC 3rd, Ukai T, Genco CA. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis[J]. Front Biosci, 2008(13):2041-2059. |
| [32] | Pan S, Lei L, Chen S, et al. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice[J]. Int Immunopharmacol, 2014,23(2):701-708. |
| [33] | Huang CY, Shih CM, Tsao NW, et al. The GroEL protein of Porphyromonas gingivalis regulates atherogenic phenomena in endothelial cells mediated by up-regulating toll-like receptor 4 expression[J]. Am J Transl Res, 2016,8(2):384-404. |
| [34] | Khlgatian M, Nassar H, Chou HH, et al. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells[J]. Infect Immun, 2002,70(1):257-267. |
| [35] | Gitlin JM, Loftin CD. Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice[J]. Cardiovasc Res, 2009,81(2):400-407. |
| [36] | Huang KT, Kuo L, Liao JC. Lipopolysaccharide activates endothelial nitric oxide synthase through protein tyrosine kinase[J]. Biochem Biophys Res Commun, 1998,245(1):33-37. |
| [37] | Obermeier F, Gross V, Scholmerich J, et al. Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide[J]. J Leukoc Biol, 1999,66(5):829-836. |
| [38] | Sorescu D, Weiss D, Lassègue B. Superoxide production and expression of nox family proteins in human atherosclerosis[J]. Circulation, 2002,105(12):1429-1435. |
| [39] | Sz?cs K, Lassègue B, Sorescu D, et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury[J]. Arterioscler Thromb Vasc Biol, 2002,22(1):21-27. |
| [40] | Anrather J, Racchumi G, Iadecola C. NF-kappaB regulates pha-gocytic NADPH oxidase by inducing the expression of gp91phox[J]. J Biol Chem, 2006,281(9):5657-5667. |
| [41] | Morris KR, Lutz RD, Choi HS, et al. Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide[J]. Infect Immun, 2003,71(3):1442-1452. |
| [42] | Deng WG, Zhu Y, Wu KK. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation[J]. J Biol Chem, 2003,278(7):4770-4777. |
| [43] | Brown K, Gerstberger S, Carlson L, et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation[J]. Science, 1995,267(5203):1485-1488. |
| [44] | Luoma JS, Stralin P, Marklund SL, et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins[J]. Arterioscler Thromb Vasc Biol, 1998,18(2):157-167. |
| [45] | Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappa B signaling[J]. Cell Res, 2011,21(1):103-115. |
| [46] | Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis[J]. Physiol Rev, 2004,84(4):1381-1478. |
/
| 〈 |
|
〉 |
